Skip to content
OpenCapital
Get started

Gain Therapeutics GANX Q1 2026 earnings

Reported May 11, 2026 · Before market open

EPS-$0.13In line
Revenue estimate$33.3K
EPS estimate-$0.13

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$33.3K
EPS estimate-$0.14

Versus estimates

Diluted EPS

Q1 2026-$0.13In line
Q4 2025-$0.11Beat by $0.03Q3 2025-$0.15In lineQ2 2025-$0.19Miss by $0.02Q1 2025-$0.16In lineQ4 2024-$0.11Beat by $0.07

Ask the moment Gain Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Gain Therapeutics report Q1 2026 earnings?
Gain Therapeutics (GANX) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Gain Therapeutics's Q1 2026 revenue and EPS?
Gain Therapeutics reported eps of $-0.13 for Q1 2026.
Did Gain Therapeutics beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.13 by $0.00.
How did Gain Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 18.8% from $-0.16.
Where can I find Gain Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-058636) and the 10-Q periodic report (0001104659-26-058649) directly on SEC EDGAR. The filing index links above go to sec.gov.